 Connection
John Jefferson to Tissue Plasminogen Activator
This is a "connection" page, showing publications John Jefferson has written about Tissue Plasminogen Activator.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.049 |
|
|
|
-
Warach SJ, Dula AN, Milling TJ, Miller S, Allen L, Zuck ND, Miller C, Jesser CA, Misra LR, Miley JT, Mawla M, Ding MC, Bertelson JA, Tsui AY, Jefferson JR, Davison HM, Shah DN, Ellington KT, Padrick MM, Nova AS, Krishna VR, Davis LA, Paydarfar D. Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice. Stroke. 2022 12; 53(12):3583-3593.
Score: 0.049
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|